RNS Number:9767J
Keryx Biopharmaceuticals Inc
11 April 2003

Keryx Biopharmaceuticals, Inc ("the Company")

Purchase of own shares for cancellation

The Company purchased on the open market 1,500 shares of its common stock for
cancellation at a price of $1.1633 per share on 10 April 2003.

11 April 2003

Contact:

Mr Bob Trachtenberg

General Counsel, Keryx Biopharmaceuticals, Inc.

Tel: 00 972 2541 3500



                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

POSIBMRTMMBBBAJ